PATRICK LE CHEVALIER

Dr. PATRICK LE CHEVALIER


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 July 2016 in Marine Drugs
Verified
Journal Article
Open access
PDF file
COClément Offret
Clément Offret
FDFlorie Desriac
Florie Desriac
PCPATRICK LE CHEVALIER
PATRICK LE CHEVALIER
Jerome MOUNIERJerome MOUNIER
Jerome MOUNIER
CJCamille Jégou
Camille Jégou
YFYannick Fleury
Yannick Fleury
This review is dedicated to the antimicrobial metabolite-producing Pseudoalteromonas strains. The genus Pseudoalteromonas hosts 41 species, among which 16 are antimicrobial metabolite producers. To date, a total of 69 antimicrobial compounds belonging to 18 different families have been documented. They are classified into alkaloids, polyketides, and peptides. Finally as Pseudoalteromonas strains are frequently associated with macroorganisms, we can discuss the ecological significance of antimicrobial Pseudoalteromonas as part of the resident microbiota.

4 April 2010 in Marine Drugs
Verified
Journal Article
Open access
PDF file
FDFlorie Desriac
Florie Desriac
DDDiane Defer
Diane Defer
Nathalie BourgougnonNathalie Bourgougnon
Nathalie Bourgougnon
BBBenjamin Brillet
Benjamin Brillet
PCPATRICK LE CHEVALIER
PATRICK LE CHEVALIER
YFYannick Fleury
Yannick Fleury
As the association of marine animals with bacteria has become more commonly recognized, researchers have increasingly questioned whether these animals actually produce many of the bioactive compounds originally isolated from them. Bacteriocins, ribosomally synthesized antibiotic peptides, constitute one of the most potent weapons to fight against pathogen infections. Indeed, bacteriocinogenic bacteria may prevent pathogen dissemination by occupying the same ecological niche. Bacteriocinogenic strains associated with marine animals are a relevant source for isolation of probiotics. This review draws up an inventory of the marine bacteriocinogenic strains isolated from animal-associated microbial communities, known to date. Bacteriocin-like inhibitory substances (BLIS) and fully-characterized bacteriocins are described. Finally, their applications as probiotics in aquaculture are discussed.

30 September 2013 in Marine Drugs
Verified
Journal Article
Open access
PDF file
FDFlorie Desriac
Florie Desriac
CJCamille Jégou
Camille Jégou
EBEric Balnois
Eric Balnois
BBBenjamin Brillet
Benjamin Brillet
PCPATRICK LE CHEVALIER
PATRICK LE CHEVALIER
YFYannick Fleury
Yannick Fleury
After years of inadequate use and the emergence of multidrug resistant (MDR) strains, the efficiency of “classical” antibiotics has decreased significantly. New drugs to fight MDR strains are urgently needed. Bacteria hold much promise as a source of unusual bioactive metabolites. However, the potential of marine bacteria, except for Actinomycetes and Cyanobacteria, has been largely underexplored. In the past two decades, the structures of several antimicrobial compounds have been elucidated in marine Proteobacteria. Of these compounds, polyketides (PKs), synthesised by condensation of malonyl-coenzyme A and/or acetyl-coenzyme A, and non-ribosomal peptides (NRPs), obtained through the linkage of (unusual) amino acids, have recently generated particular interest. NRPs are good examples of naturally modified peptides. Here, we review and compile the data on the antimicrobial peptides isolated from marine Proteobacteria, especially NRPs.

6 February 2018 in Probiotics and Antimicrobial Proteins
Verified
Journal Article
Closed access
PDF file
COClément Offret
Clément Offret
VRVincent Rochard
Vincent Rochard
HLHélène Laguerre
Hélène Laguerre
Jerome MOUNIERJerome MOUNIER
Jerome MOUNIER
SHSylvain Huchette
Sylvain Huchette
YFYannick Fleury
Yannick Fleury

10 December 2020 in Marine Drugs
Verified
Journal Article
Open access
PDF file
FDFlorie Desriac
Florie Desriac
AHABDERRAFEK EL HARRAS
ABDERRAFEK EL HARRAS
MSMatthieu Simon
Matthieu Simon
ABArnaud Bondon
Arnaud Bondon
BBBenjamin Brillet
Benjamin Brillet
YFYannick Fleury
Yannick Fleury
Discovery after discovery, host-associated microbiota reveal a growing list of positive effects on host homeostasis by contributing to host nutrition, improving hosts’ immune systems and protecting hosts against pathogens. In that context, a collection of oyster associated bacteria producing antibacterial compounds have been established to evaluate their role in non-host-derived immunity. Here, we described alterins; potent anti-Gram negative compounds produced by Pseudoalteromonas hCg-6 and hCg-42 isolated from different healthy oyster hemolymph. The strains hCg-6 and hCg-42 produce a set of at least seven antibacterial compounds, ranging from 926 to 982 Da structurally characterized as cyclolipopeptides (CLPs). Alterins share the same cationic heptapeptidic cycle connected via an amido bond to different hydrophobic hydrocarbon tails. Their MICs disclosed a potent antibacterial activity directed against Gram-negative bacteria including oyster and human pathogens that may confer a beneficial defense mechanism to the host but also represents an untapped source of new antibiotics. The alterins’ mechanisms of action have been deciphered: after binding to lipopolysaccharides (LPS), alterins provoke a membrane depolarization and permeabilization leading to bacterial lysis. As hCg-6 and hCg-42 produced a set of natural derivatives, the structure/activity relationship linked to the carbon tail is clarified. We showed that the hydrocarbon tail determines the LPS-binding properties of alterins and consequently their antibacterial activities. Its length and saturation seem to play a major role in this interaction.

26 December 2018 in Journal of Applied Microbiology
Verified
Journal Article
Closed access
PDF file
COClément Offret
Clément Offret
CJCamille Jégou
Camille Jégou
Jerome MOUNIERJerome MOUNIER
Jerome MOUNIER
YFYannick Fleury
Yannick Fleury
PCPATRICK LE CHEVALIER
PATRICK LE CHEVALIER